- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02427555
Effects of Barley Based Food Products on Metabolism and Gut Microflora
May 16, 2016 updated by: Anne Nilsson, Lund University
The main objective is to investigate gut microflora composition in relation to cardiometabolic risk markers, and to investigate the effects of 3 days intervention with a barley kernel based product on these variables.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
100 subjects were invited to deliver faecal samples.
From this cohort 40 subjects were chosen based on their gut microflora composition to participate in the Barley intervention.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lund, Sweden, , SE-223 81 LUND
- Food for Health Science Centre, Medicon Village, Lund University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy men and women between 50-79 years and
- BMI between 19-28.
Exclusion Criteria:
- fasting blood glucose concentrations > 6,1 mmol/L,
- known metabolic disorders or gastrointestinal diseases or other disorders that can interfere with the results of the study.
- furthermore, the subjects should be non-smokers and
- consume a normal (non-vegetarian) diet as is recommended by the Nordic dietary guidelines.
- antibiotics or probiotics should not have been taken during four weeks prior to faeces donation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Barley kernel bread
|
3 days intervention with barley kernel bread
|
|
Sham Comparator: Whit wheat flour bread
|
3 days intervention with white wheat bread
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in glucose regulation
Time Frame: Changes in fasting and postprandial blood glucose concentrations after 3 days intervention with a barley based bread in comparison to 3 days intervention with a white wheat based bread
|
blood glucose concentrations are measured fasting and postprandially a standardised breakfast after interventions with barley based bread and white wheat bread, respectively
|
Changes in fasting and postprandial blood glucose concentrations after 3 days intervention with a barley based bread in comparison to 3 days intervention with a white wheat based bread
|
|
Changes in colonic microbiota composition after intervention with barley
Time Frame: Changes in colonic microbiota composition after 3 days intervention with a barley based bread in comparison to 3 days intervention with a white wheat based bread
|
Gut microbiota composition are characterised after interventions with barley based bread and white wheat bread, respectively
|
Changes in colonic microbiota composition after 3 days intervention with a barley based bread in comparison to 3 days intervention with a white wheat based bread
|
|
nucleotide polymorphisms (SNP in TCF7L2)
Time Frame: at baseline
|
investigate nucleotide polymorphisms that associate with cardiometabolic traits, in particular the SNP in TCF7L2
|
at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Anne Nilsson, PhD, Food for Health Science Centre, Medicon Village, Lund University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
April 17, 2015
First Submitted That Met QC Criteria
April 22, 2015
First Posted (Estimate)
April 28, 2015
Study Record Updates
Last Update Posted (Estimate)
May 17, 2016
Last Update Submitted That Met QC Criteria
May 16, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- AFC-Y8-2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationNot yet recruiting
-
Central Hospital, Nancy, FranceRecruitingHealthy SubjectsFrance
-
Lutroo Imaging LLCStanford UniversityRecruiting
Clinical Trials on Barley kernel bread
-
University of AberdeenCompletedType 2 DiabetesUnited Kingdom
-
TC Erciyes UniversityCompleted
-
University of CopenhagenCompletedMetabolic Syndrome
-
Arizona State UniversityArdent Mills, LLCCompletedBlood Glucose | Hunger | Dietary FiberUnited States
-
University of TorontoCompleted
-
University of JenaCompletedGlucose Metabolism | Lipid Metabolism | SatietyGermany
-
Institut de Recherche pour le DeveloppementPATH; Department of Fisheries Post-harvest Technologies and Quality Control; World...Completed
-
Khyber Medical University PeshawarCompletedCardiovascular Diseases | Kidney DiseasesPakistan
-
Malaysia Palm Oil BoardIMU University, MalaysiaActive, not recruiting
-
KernelAcacia ClinicsRecruitingMajor Depressive Disorder (MDD) | fNIRSUnited States